Praxis Impact Large Cap Growth ETF (PRXG)

On our desk, we are monitoring PRXG's heavy tilt toward mega-cap technology, with NVIDIA, Apple, and Microsoft alone making up over 35% of the portfolio. While its faith-based stewardship and ESG screening offer a distinct mandate via Praxis Investment Management, the concentration risk is very real. Investors looking at the fund's 35.82 P/E multiple must weigh whether the strict stewardship criteria justify tracking error relative to traditional large-cap growth benchmarks, especially given Morningstar's quantitatively derived Neutral rating.

Looking at the quantitative profile on our desk, PRXG stands out for its remarkably low portfolio turnover rate of just 13%, compared to a 74% average for the Large Growth category. This structural efficiency keeps tax-cost ratios near zero and supports a steadier holding strategy. However, with a market capitalization of $87.56M and an average daily volume tracking around 6.15K shares against recent volumes of 9.69K, liquidity and secondary market trading spreads warrant close monitoring for institutional execution.

From a clinical portfolio construction perspective, evaluating an active ETF like PRXG requires looking past the 14.1% annualized 1-year NAV return and examining the underlying risk parameters. The fund operates without an index tracking mandate, meaning alpha generation relies entirely on manager execution within its ESG and faith-based constraints. Analysts interviewing or structuring allocations around this vehicle need to account for investment style risk—specifically, how growth cycles and interest rate paths will impact its top holdings in communication services and consumer cyclicals.